FibroGen Reports First Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/1/2026
- Wall Street ends choppy session lower as tech shares drop
- Meta Platforms stock surges 8% on cloud business plans
- Humanoid robot component stocks surge on supply-chain optimism
- Oil prices fall 1% to 4-month lows as progress in US-Iran talks cools supply concerns
- Trump discloses over $1.4 billion in crypto income in 2025 filing
- Whirlpool to close Mexico plant, expects $165M restructuring cost
- S&P 500, Nasdaq register best quarter since 2020 despite Iran war
- Cantor Fitzgerald Starts Forward Industries (FWDI) at Overweight
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- DISH DBS files prepackaged chapter 11 to repay debt, wind down wireless
FibroGen (FGEN) Tops Q1 EPS by 9c, Revenues Miss
May 10, 2021 4:55 PM EDTFibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.78), $0.09 better than the analyst estimate of ($0.87). Revenue for the quarter came in at $38.43 million versus the consensus estimate of $41.79 million.
We are pleased at the continued adoption and growth of roxadustat in China, said Enrique Conterno, Chief... More
